Studies have shown HSA to be an effective marker that may be used in a panel with CEA (Carcinoembryonic Antigen), CK7, AFP (Alpha Fetoprotein) and CD10 to aid in the differential diagnosis of hepatocellular carcinoma from cholangiocarcinoma and/or metastatic adenocarcinoma. Specifications

WEIGHT	N/A
DIMENSIONS	N/A
INTENDED USE	RUO
SPECIES REACTIVITY	Human
SOURCE	Mouse Monoclonal
CLONE	OCH1E5
ISOTYPE	IgG1/kappa
ANTIGEN	Hepatocyte Specific Antigen
LOCALIZATION	Cytoplasmic
POSITIVE CONTROL	Liver or liver carcinoma